In the present study, we investigated whether the circulating pool of CD4+CD25+ Treg in patients with SCCHN was expanded relative to that in NC and evaluated phenotypic and functional characterisitics of Treg. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.